Cycle 4: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

Sponsor: National Institutes of Health (multiple Institutes)
LOI Due Date: July 10, 2017
Application Due Date: August 9, 2022
Award: Actual needs; applicants should rarely exceed up to $500,000 total cost per year for Phase I and up to $1,500,000 total cost per year for the Phase II.